Skip to main content
Top
Published in: Journal of Experimental & Clinical Cancer Research 1/2010

Open Access 01-12-2010 | Research

Klotho inhibits growth and promotes apoptosis in human lung cancer cell line A549

Authors: Bo Chen, Xueli Wang, Weihong Zhao, Jianqing Wu

Published in: Journal of Experimental & Clinical Cancer Research | Issue 1/2010

Login to get access

Abstract

Background

Klotho, as a new anti-aging gene, can shed into circulation and act as a multi-functional humoral factor that influences multiple biological processes. Recently, published studies suggest that klotho can also serve as a potential tumor suppressor. The aim of this study is to investigate the effects and possible mechanisms of action of klotho in human lung cancer cell line A549.

Methods

In this study, plasmids encoding klotho or klotho specific shRNAs were constructed to overexpress or knockdown klotho in vitro. A549 cells were respectively treated with pCMV6-MYC-KL or klotho specific shRNAs. The MTT assay was used to evaluate the cytotoxic effects of klotho and flow cytometry was utilized to observe and detect the apoptosis of A549 cells induced by klotho. The activation of IGF-1/insulin signal pathways in A549 cells treated by pCMV6-MYC-KL or shRNAs were evaluated by western blotting. The expression levels of bcl-2 and bax transcripts were evaluated by quantitative reverse transcription-polymerase chain reaction (qRT-PCR).

Results

Overexpression of klotho reduced the proliferation of lung cancer A549 cells, whereas klotho silencing in A549 cells enhanced proliferation. Klotho did not show any effects on HEK-293 cells. Klotho overexpression in A549 cells was associated with reduced IGF-1/insulin-induced phosphorylation of IGF-1R (IGF-1 receptor)/IR (insulin receptor) (P < 0.01). Overexpression of klotho can promote the apoptosis of A549 cells (P < 0.01). Overexpression of klotho, a bcl family gene bax, was found up-regulated and bcl-2, an anti-apoptosis gene, was found down-regulated (P < 0.01). In contrast, bax and bcl-2 were found down-regulated (P < 0.05) and up-regulated (P < 0.01), respectively when silencing klotho using shRNAs.

Conclusions

Klotho can inhibit proliferation and increase apoptosis of A549 cells, this may be partly due to the inhibition of IGF-1/insulin pathways and involving regulating the expression of the apoptosis-related genes bax/bcl-2. Thus, klotho can serve as a potential tumor suppressor in A549 cells.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ: Cancer statistics. CA Cancer J Clin. 2009, 59: 225-249. 10.3322/caac.20006.CrossRef Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ: Cancer statistics. CA Cancer J Clin. 2009, 59: 225-249. 10.3322/caac.20006.CrossRef
2.
go back to reference Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E: Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997, 390: 45-51. 10.1038/36285.CrossRef Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E: Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997, 390: 45-51. 10.1038/36285.CrossRef
3.
go back to reference Kurosu H, Yamamoto M, Clark JD, Pastor JV, Nandi A, Gurnani P, McGuinness OP, Chikuda H, Yamaguchi M, Kawaguchi H: Suppression of aging in mice by the hormone Klotho. Science. 2005, 309: 1829-1833. 10.1126/science.1112766.CrossRef Kurosu H, Yamamoto M, Clark JD, Pastor JV, Nandi A, Gurnani P, McGuinness OP, Chikuda H, Yamaguchi M, Kawaguchi H: Suppression of aging in mice by the hormone Klotho. Science. 2005, 309: 1829-1833. 10.1126/science.1112766.CrossRef
4.
go back to reference Matsumura Y, Aizawa H, Shiraki-Iida T, Nagai R, Kuro-o M, Nabeshima Y: Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein. Biochem Biophys Res Commun. 1998, 242: 626-630. 10.1006/bbrc.1997.8019.CrossRef Matsumura Y, Aizawa H, Shiraki-Iida T, Nagai R, Kuro-o M, Nabeshima Y: Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein. Biochem Biophys Res Commun. 1998, 242: 626-630. 10.1006/bbrc.1997.8019.CrossRef
5.
go back to reference Shiraki-Iida T, Aizawa H, Matsumura Y, Sekine S, Iida A, Anazawa H, Nagai R, Kuro-o M, Nabeshima Y: Structure of the mouse klotho gene and its two transcripts encoding membrane and secreted protein. FEBS Lett. 1998, 424: 6-10. 10.1016/S0014-5793(98)00127-6.CrossRef Shiraki-Iida T, Aizawa H, Matsumura Y, Sekine S, Iida A, Anazawa H, Nagai R, Kuro-o M, Nabeshima Y: Structure of the mouse klotho gene and its two transcripts encoding membrane and secreted protein. FEBS Lett. 1998, 424: 6-10. 10.1016/S0014-5793(98)00127-6.CrossRef
6.
go back to reference Mian IS: Sequence, structural, functional, and phylogenetic analyses of three glycosidase families. Blood Cells Mol Dis. 1998, 24: 83-100. Mian IS: Sequence, structural, functional, and phylogenetic analyses of three glycosidase families. Blood Cells Mol Dis. 1998, 24: 83-100.
7.
go back to reference Imura A, Iwano A, Tohyama O, Tsuji Y, Nozaki K, Hashimoto N, Fujimori T, Nabeshima Y: Secreted Klotho protein in sera and CSF: implication for post-translational cleavage in release of Klotho protein from cell membrane. FEBS Lett. 2004, 565: 143-147. 10.1016/j.febslet.2004.03.090.CrossRef Imura A, Iwano A, Tohyama O, Tsuji Y, Nozaki K, Hashimoto N, Fujimori T, Nabeshima Y: Secreted Klotho protein in sera and CSF: implication for post-translational cleavage in release of Klotho protein from cell membrane. FEBS Lett. 2004, 565: 143-147. 10.1016/j.febslet.2004.03.090.CrossRef
8.
go back to reference Utsugi T, Ohno T, Ohyama Y, Uchiyama T, Saito Y, Matsumura Y, Aizawa H, Itoh H, Kurabayashi M, Kawazu S: Decreased insulin production and increased insulin sensitivity in the klotho mutant mouse, a novel animal model for human aging. Metabolism. 2000, 49: 1118-1123. 10.1053/meta.2000.8606.CrossRef Utsugi T, Ohno T, Ohyama Y, Uchiyama T, Saito Y, Matsumura Y, Aizawa H, Itoh H, Kurabayashi M, Kawazu S: Decreased insulin production and increased insulin sensitivity in the klotho mutant mouse, a novel animal model for human aging. Metabolism. 2000, 49: 1118-1123. 10.1053/meta.2000.8606.CrossRef
9.
go back to reference Tatar M, Bartke A, Antebi A: The endocrine regulation of aging by insulin-like signals. Science. 2003, 299: 1346-1351. 10.1126/science.1081447.CrossRef Tatar M, Bartke A, Antebi A: The endocrine regulation of aging by insulin-like signals. Science. 2003, 299: 1346-1351. 10.1126/science.1081447.CrossRef
10.
go back to reference Liu H, Fergusson MM, Castilho RM, Liu J, Cao L, Chen J, Malide D, Rovira II, Schimel D, Kuo CJ: Augmented Wnt signaling in a mammalian model of accelerated aging. Science. 2007, 317: 803-806. 10.1126/science.1143578.CrossRef Liu H, Fergusson MM, Castilho RM, Liu J, Cao L, Chen J, Malide D, Rovira II, Schimel D, Kuo CJ: Augmented Wnt signaling in a mammalian model of accelerated aging. Science. 2007, 317: 803-806. 10.1126/science.1143578.CrossRef
11.
go back to reference Liu S, Gupta A, Quarles LD: Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization. Curr Opin Nephrol Hypertens. 2007, 16: 329-335. 10.1097/MNH.0b013e3281ca6ffd.CrossRef Liu S, Gupta A, Quarles LD: Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization. Curr Opin Nephrol Hypertens. 2007, 16: 329-335. 10.1097/MNH.0b013e3281ca6ffd.CrossRef
12.
go back to reference Mitani H, Ishizaka N, Aizawa T, Ohno M, Usui S, Suzuki T, Amaki T, Mori I, Nakamura Y, Sato M: In vivo klotho gene transfer ameliorates angiotensin II-induced renal damage. Hypertension. 2002, 39: 838-843. 10.1161/01.HYP.0000013734.33441.EA.CrossRef Mitani H, Ishizaka N, Aizawa T, Ohno M, Usui S, Suzuki T, Amaki T, Mori I, Nakamura Y, Sato M: In vivo klotho gene transfer ameliorates angiotensin II-induced renal damage. Hypertension. 2002, 39: 838-843. 10.1161/01.HYP.0000013734.33441.EA.CrossRef
13.
go back to reference Saito Y, Nakamura T, Ohyama Y, Suzuki T, Iida A, Shiraki-Iida T, Kuro-o M, Nabeshima Y, Kurabayashi M, Nagai R: In vivo klotho gene delivery protects against endothelial dysfunction in multiple risk factor syndrome. Biochem Biophys Res Commun. 2000, 276: 767-772. 10.1006/bbrc.2000.3470.CrossRef Saito Y, Nakamura T, Ohyama Y, Suzuki T, Iida A, Shiraki-Iida T, Kuro-o M, Nabeshima Y, Kurabayashi M, Nagai R: In vivo klotho gene delivery protects against endothelial dysfunction in multiple risk factor syndrome. Biochem Biophys Res Commun. 2000, 276: 767-772. 10.1006/bbrc.2000.3470.CrossRef
14.
go back to reference Hofmann F, García-Echeverría C: Blocking the insulin-like growth factor-I receptor as a strategy for targeting cancer. Drug Discov Today. 2005, 10: 1041-1047. 10.1016/S1359-6446(05)03512-9.CrossRef Hofmann F, García-Echeverría C: Blocking the insulin-like growth factor-I receptor as a strategy for targeting cancer. Drug Discov Today. 2005, 10: 1041-1047. 10.1016/S1359-6446(05)03512-9.CrossRef
15.
go back to reference Tao Y, Pinzi V, Bourhis J, Deutsch E: Mechanisms of disease: signaling of the insulin-like growth factor 1 receptor pathway-therapeutic perspectives in cancer. Nat Clin Pract Oncol. 2007, 4: 591-602. 10.1038/ncponc0934.CrossRef Tao Y, Pinzi V, Bourhis J, Deutsch E: Mechanisms of disease: signaling of the insulin-like growth factor 1 receptor pathway-therapeutic perspectives in cancer. Nat Clin Pract Oncol. 2007, 4: 591-602. 10.1038/ncponc0934.CrossRef
16.
go back to reference Yu H, Spitz MR, Mistry J, Gu J, Hong WK, Wu X: Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. J Natl Cancer Inst. 1999, 91: 151-156. 10.1093/jnci/91.2.151.CrossRef Yu H, Spitz MR, Mistry J, Gu J, Hong WK, Wu X: Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. J Natl Cancer Inst. 1999, 91: 151-156. 10.1093/jnci/91.2.151.CrossRef
17.
go back to reference Mattarocci S, Abbruzzese C, Mileo AM, Visca P, Antoniani B, Alessandrini G, Facciolo F, Felsani A, Radulescu RT, Paggi MG: Intracellular presence of insulin and its phosphorylated receptor in non-small cell lung cancer. J Cell Physiol. 2009, 221: 766-770. 10.1002/jcp.21916.CrossRef Mattarocci S, Abbruzzese C, Mileo AM, Visca P, Antoniani B, Alessandrini G, Facciolo F, Felsani A, Radulescu RT, Paggi MG: Intracellular presence of insulin and its phosphorylated receptor in non-small cell lung cancer. J Cell Physiol. 2009, 221: 766-770. 10.1002/jcp.21916.CrossRef
18.
go back to reference Ma Z, Dong A, Kong M, Qian J: Silencing of the type 1 insulin-like growth factor receptor increases the sensitivity to apoptosis and inhibits invasion in human lung adenocarcinoma A549 cells. Cell Mol Biol Lett. 2007, 12: 556-572. 10.2478/s11658-007-0022-1.CrossRef Ma Z, Dong A, Kong M, Qian J: Silencing of the type 1 insulin-like growth factor receptor increases the sensitivity to apoptosis and inhibits invasion in human lung adenocarcinoma A549 cells. Cell Mol Biol Lett. 2007, 12: 556-572. 10.2478/s11658-007-0022-1.CrossRef
19.
go back to reference Wolf I, Levanon-Cohen S, Bose S, Ligumsky H, Sredni B, Kanety H, Kuro-o M, Karlan B, Kaufman B, Koeffler HP, Rubinek T: Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer. Oncogene. 2008, 27: 7094-7105. 10.1038/onc.2008.292.CrossRef Wolf I, Levanon-Cohen S, Bose S, Ligumsky H, Sredni B, Kanety H, Kuro-o M, Karlan B, Kaufman B, Koeffler HP, Rubinek T: Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer. Oncogene. 2008, 27: 7094-7105. 10.1038/onc.2008.292.CrossRef
20.
go back to reference Dong AQ, Kong MJ, Ma ZY, Qian JF, Xu XH: Down-regulation of IGF-IR using small, interfering, hairpin RNA (siRNA) inhibits growth of human lung cancer cell line A549 in vitro and in nude mice. Cell Biol Int. 2007, 31: 500-507. 10.1016/j.cellbi.2006.11.017.CrossRef Dong AQ, Kong MJ, Ma ZY, Qian JF, Xu XH: Down-regulation of IGF-IR using small, interfering, hairpin RNA (siRNA) inhibits growth of human lung cancer cell line A549 in vitro and in nude mice. Cell Biol Int. 2007, 31: 500-507. 10.1016/j.cellbi.2006.11.017.CrossRef
21.
go back to reference de Oliveira RM: Klotho RNAi induces premature senescence of human cells via a p53/p21 dependent pathway. FEBS Lett. 2006, 580: 5753-5758. 10.1016/j.febslet.2006.09.036.CrossRef de Oliveira RM: Klotho RNAi induces premature senescence of human cells via a p53/p21 dependent pathway. FEBS Lett. 2006, 580: 5753-5758. 10.1016/j.febslet.2006.09.036.CrossRef
22.
go back to reference Yang J, Matsukawa N, Rakugi H, Imai M, Kida I, Nagai M, Ohta J, Fukuo K, Nabeshima Y, Ogihara T: Upregulation of cAMP is a new functional signal pathway of Klotho in endothelial cells. Biochem Biophys Res Commun. 2003, 301: 424-429. 10.1016/S0006-291X(02)03056-5.CrossRef Yang J, Matsukawa N, Rakugi H, Imai M, Kida I, Nagai M, Ohta J, Fukuo K, Nabeshima Y, Ogihara T: Upregulation of cAMP is a new functional signal pathway of Klotho in endothelial cells. Biochem Biophys Res Commun. 2003, 301: 424-429. 10.1016/S0006-291X(02)03056-5.CrossRef
23.
go back to reference Thomadaki H, Scorilas A: Molecular profile of the BCL2 family of the apoptosis related genes in breast cancer cells after treatment with cytotoxic/cytostatic drugs. Connect Tissue Res. 2008, 49: 261-264. 10.1080/03008200802147829.CrossRef Thomadaki H, Scorilas A: Molecular profile of the BCL2 family of the apoptosis related genes in breast cancer cells after treatment with cytotoxic/cytostatic drugs. Connect Tissue Res. 2008, 49: 261-264. 10.1080/03008200802147829.CrossRef
24.
go back to reference Hengartner MO: The biochemistry of apoptosis. Nature. 2000, 407: 770-776. 10.1038/35037710.CrossRef Hengartner MO: The biochemistry of apoptosis. Nature. 2000, 407: 770-776. 10.1038/35037710.CrossRef
25.
go back to reference Gajewski TF, Thompson CB: Apoptosis meets signal transduction: elimination of a BAD influence. Cell. 1996, 87: 589-592. 10.1016/S0092-8674(00)81377-X.CrossRef Gajewski TF, Thompson CB: Apoptosis meets signal transduction: elimination of a BAD influence. Cell. 1996, 87: 589-592. 10.1016/S0092-8674(00)81377-X.CrossRef
26.
go back to reference Zhang K, Kaufman RJ: From endoplasmic-reticulum stress to the inflammatory response. Nature. 2008, 454: 455-462. 10.1038/nature07203.CrossRef Zhang K, Kaufman RJ: From endoplasmic-reticulum stress to the inflammatory response. Nature. 2008, 454: 455-462. 10.1038/nature07203.CrossRef
Metadata
Title
Klotho inhibits growth and promotes apoptosis in human lung cancer cell line A549
Authors
Bo Chen
Xueli Wang
Weihong Zhao
Jianqing Wu
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Journal of Experimental & Clinical Cancer Research / Issue 1/2010
Electronic ISSN: 1756-9966
DOI
https://doi.org/10.1186/1756-9966-29-99

Other articles of this Issue 1/2010

Journal of Experimental & Clinical Cancer Research 1/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine